ARTG 448868Hollow-fibre haemodialysis dialyser, high flux, single-use
ARTG ID: 448868 · Nipro Australia Pty Ltd · Nipro Corporation · Class IIb · Started May 16, 2024
Good Name: Nipro Australia Pty Ltd - Hollow-fibre haemodialysis dialyser, high flux, single-use
- Risk Class
- Class IIb
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 448868
- Start Date
- May 16, 2024
- Effective Date
- May 16, 2024
- Country
- Japan
- Address
- 3-26 Senriokashinmachi, Settsu, Osaka, 566-8510
Haemodialysis or Hemodiafiltration with Elisio-H (or -K) is indicated for patients having acute or chronic renal failure when dialysis is prescribed by the physician. Haemodialysis with Elisio-M and -L is indicated for patients having acute or chronic renal failure when dialysis is prescribed by the physician.
Access comprehensive regulatory information for Hollow-fibre haemodialysis dialyser, high flux, single-use in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 448868 and sponsored by Nipro Australia Pty Ltd, manufactured by Nipro Corporation in Japan. The device registration started on May 16, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.